ANDA 40785, held by Wockhardt Bio AG. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 40785 (Promethazine Hydrochloride), held by Wockhardt Bio AG, was first approved by FDA on Sep 26, 2008, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 26, 2008 | Original application | Approved | None posted |
| Promethazine Hydrochloride25MG/ML · injectable;injection | Promethazine Hydrochloride | Discontinued |
| Promethazine Hydrochloride50MG/ML · injectable;injection | Promethazine Hydrochloride | Discontinued |
| Feb 13, 2015 | Supplement 1Labeling | Approved | None posted |
| Dec 11, 2009 | Supplement 2Labeling | Approved | None posted |
| Sep 26, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters